According to our current results, MEAO blocked the increase in GRP78, CHOP and XBP-1x splicing respectively, suggesting that MEAO potentially acts on hepatic steatosis via inhibition of the three branches of UPR. The gene discussed is DDIT3; the disease is fatty liver disease.